Seletracetam | UCB
UCB's Global Corporate Website

Seletracetam

Disease area studied Abbreviated title Phase Study ID Registry database Study results Plain language summary Publication (if available)
Epilepsy Phase 2 N01191
Completed
NCT00152451
Epilepsy Phase 2 N01192
Completed
NCT00152503
Epilepsy Phase 3 N01197
Terminated
NCT00175851
Epilepsy Phase 2 N01272
Terminated
NCT00422110